Is Compounding A Practical Opportunity For Your Pharmacy? | Pharmacy CrossRoads

Is Compounding A Practical Opportunity For Yo...

Up next

Building a Diverse Content Strategy That Works | Marketing Vitals

A strong marketing strategy depends on the variety and relevance of your content. In this episode, we dive into what a diverse content strategy is, why it matters, and how it can elevate your marketing efforts. We’ll highlight the key benefits of producing varied content, common ...  Show more

Understanding Mineral Deficiency & Metal Toxicity with Jeff Lioon | The Holistic Pharmacy Podcast

Today’s guest shares my mission to empower others to take control of their health and address the root cause. We talk about challenges to testing and addressing the foundations of health, which begins with Minerals & Metals. Jeff Lioon is the Creative Director at The Oligoscan. H ...  Show more

Recommended Episodes

The Future of Personalized Medicine | Shaun Noorian
The Dr. Gabrielle Lyon Show

In this episode of the Dr. Gabrielle Lyon Show, we dive deep into the world of compounding pharmacies and the transformative power of anabolic steroids with special guest Shaun Noorian, founder of Empower Pharmacy, one of the largest compounding pharmacies in the U.S.Join us as S ...  Show more

531: Growing a Medical Practice with Dr. Rao
The How of Business - How to start, run, grow and exit a small business.

How to grow a Medical Practice with Dr. Ramesh Rao.

<span style= "mso-bookmark: _Hlk160446384;">Show Notes Page:</span> <span style="mso-bookmark: _Hlk160446384; ...

  Show more

What Every Medical Student Should Know About Integrative Medicine
Spoonful of Sugar

Have you heard of the specialty of integrative medicine? What is it, and how does an integrative medicine physician care for their patients? In this episode, Ria interviews Dr. Chiti Parikh, who is board certified in integrative medicine and is the executive director of the Integ ...  Show more

FDA ends GLP-1 compounding for semaglutide, tirzepatide
Healthcare Strategies

FDA’s removal of GLP-1 drugs from the shortage list ends supplemental compounding, shifting patient access back to branded semaglutide and tirzepatide. Featuring: Sara Heath, executive editor, Xtelligent Healthcare Alivia Kaylor, senior editor of Pharma Life Sciences, Xtelligent ...  Show more